<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Eur Heart J</journal-id>
      <journal-id journal-id-type="iso-abbrev">Eur. Heart J</journal-id>
      <journal-id journal-id-type="publisher-id">eurheartj</journal-id>
      <journal-id journal-id-type="hwp">ehj</journal-id>
      <journal-title-group>
        <journal-title>European Heart Journal</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0195-668X</issn>
      <issn pub-type="epub">1522-9645</issn>
      <publisher>
        <publisher-name>Oxford University Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24513792</article-id>
      <article-id pub-id-type="pmc">4048536</article-id>
      <article-id pub-id-type="doi">10.1093/eurheartj/ehu009</article-id>
      <article-id pub-id-type="publisher-id">ehu009</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Cardiovascular Flashlights</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>First in-human robotic rotor ablation for atrial fibrillation</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Lin</surname>
            <given-names>Tina</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kuck</surname>
            <given-names>Karl-Heinz</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ouyang</surname>
            <given-names>Feifan</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tilz</surname>
            <given-names>Roland Richard</given-names>
          </name>
          <xref ref-type="corresp" rid="cor1">*</xref>
        </contrib>
        <aff><addr-line>Department of Cardiology</addr-line>, <institution>Asklepios Klinik St Georg</institution>, <addr-line>Lohm&#xFC;hlenstra&#xDF;e 5, Hamburg 20099</addr-line>, <country>Germany</country></aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1"><label>*</label>Corresponding author. Tel: +49 401818853616, Fax: +49 401818854435, Email: <email>tilz6@hotmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>07</day>
        <month>6</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>09</day>
        <month>2</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>09</day>
        <month>2</month>
        <year>2014</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. -->
      <volume>35</volume>
      <issue>22</issue>
      <issue-title>Focus Issue on Atrial Fibrillation</issue-title>
      <fpage>1432</fpage>
      <lpage>1432</lpage>
      <permissions>
        <copyright-statement>&#xA9; The Author 2014. Published by Oxford University Press on behalf of the European Society of Cardiology.</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:type="simple" xlink:href="ehu009.pdf"/>
    </article-meta>
  </front>
  <body><p>Pulmonary vein isolation (PVI) is the cornerstone of most atrial fibrillation (AF) ablation procedures. Recent studies demonstrate that in AF, rapidly activating spiral-circuits called &#x2018;rotors&#x2019; can be localized with computational-mapping during an electrophysiological study. Radiofrequency ablation at the rotor may result in AF termination. Remote robotic-navigation (RN) is designed to improve catheter stability and decrease radiation exposure.</p><p>We report the first in-human rotor-mapping with a novel 64-electrode basket catheter (FIRMap<sup>&#xAE;</sup>, Topera) (<italic>Panel A</italic>) and mapping system (RhythmView<sup>&#xAE;</sup>, Topera) combined with a RN system (Sensei&#x2122;, Hansen Medical), and assessed its feasibility for rotor-modulation and PVI.</p><p>A 73-year-old male with paroxysmal AF and no structural heart disease was referred for ablation. Two long sheaths were advanced into the left atrium (LA). Atrial fibrillation was induced with burst pacing from the septal PVs, and sustained for &gt;5 min before a 60 mm FIRMap<sup>&#xAE;</sup> basket catheter (<italic>Panel B</italic>) was used to map for rotors in both atria.</p><p>No rotors were identified in the right atrium. A rotor was identified at the LA mid-posterior wall near the right PV antrum before circumferential PVI (<italic>Panels C</italic> and <italic>D</italic>, <ext-link ext-link-type="uri" xlink:href="http://eurheartj.oxfordjournals.org/lookup/suppl/doi:10.1093/eurheartj/ehu009/-/DC1">Supplementary material online, <italic>Video</italic></ext-link>). Radiofrequency current (30 W) was applied for 300 s using the RN Artisan<sup>&#xAE;</sup> Extend catheter (Hansen Medical) and resulted in coronary sinus cycle-length prolongation (150 to 170 ms). Atrial fibrillation termination occurred 72 s after rotor ablation (<italic>Panel E</italic>). Repeat rotor-mapping confirmed no further rotors. Ipsilateral PVI was then performed, and AF was no longer inducible. Fluoroscopy time was 22 min, and fluoroscopy dose was 3125 cGycm<sup>2</sup>. Oesophageal temperature-monitoring during ablation and gastroscopy post-procedure showed no oesophageal thermal lesions, and echocardiography found no pericardial effusion.</p><p>The combination of RN and rotor ablation using the novel FIRMap<sup>&#xAE;</sup> catheter is feasible.</p><p><bold>Funding:</bold> Funding to pay the Open Access publication charges for this article was provided by Topera Medical.</p><p><fig id="EHU009F1" position="float"><graphic xlink:href="ehu00901"/></fig></p><p><ext-link ext-link-type="uri" xlink:href="http://eurheartj.oxfordjournals.org/lookup/suppl/doi:10.1093/eurheartj/ehu009/-/DC1">Supplementary material is available at <italic>European Heart Journal</italic> online.</ext-link></p>
<sec sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material id="PMC_1" content-type="local-data">
<caption>
<title>Supplementary Data</title>
</caption>
<media mimetype="text" mime-subtype="html" xlink:href="supp_35_22_1432__index.html"/>
<media xlink:role="associated-file" mimetype="application" mime-subtype="vnd.ms-powerpoint" xlink:href="supp_ehu009_ehu009supp.pptx"/>
<media xlink:role="associated-file" mimetype="video" mime-subtype="mpeg" xlink:href="supp_ehu009_ehu009supp_movie1.mpg"/>
<media xlink:role="associated-file" mimetype="video" mime-subtype="mpeg" xlink:href="supp_ehu009_ehu009supp_movie2.mpg"/>
</supplementary-material>
</sec>
</body>
</article>
</pmc-articleset>
